Munich Reinsurance Co Stock Corp in Munich Sells 34,983 Shares of Morgan Stanley $MS

Munich Reinsurance Co Stock Corp in Munich lessened its position in Morgan Stanley (NYSE:MS) by 74.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,860 shares of the financial services provider’s stock after selling 34,983 shares during the quarter. Munich Reinsurance Co Stock Corp in Munich’s holdings in Morgan Stanley were worth $2,479,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of the company. Mitsubishi UFJ Financial Group Inc. bought a new stake in shares of Morgan Stanley in the second quarter worth $78,825,883,310. State Street Corp boosted its holdings in Morgan Stanley by 0.5% during the fourth quarter. State Street Corp now owns 103,854,751 shares of the financial services provider’s stock worth $18,437,334,000 after purchasing an additional 539,544 shares during the last quarter. Geode Capital Management LLC grew its position in Morgan Stanley by 2.0% in the fourth quarter. Geode Capital Management LLC now owns 27,070,557 shares of the financial services provider’s stock valued at $4,786,350,000 after purchasing an additional 534,708 shares in the last quarter. Fisher Asset Management LLC increased its stake in Morgan Stanley by 2.1% in the 4th quarter. Fisher Asset Management LLC now owns 25,018,335 shares of the financial services provider’s stock valued at $4,441,505,000 after buying an additional 524,189 shares during the last quarter. Finally, Bank of America Corp DE increased its stake in Morgan Stanley by 0.5% in the 1st quarter. Bank of America Corp DE now owns 16,326,676 shares of the financial services provider’s stock valued at $2,686,881,000 after buying an additional 87,533 shares during the last quarter. Institutional investors own 84.19% of the company’s stock.

Key Headlines Impacting Morgan Stanley

Here are the key news stories impacting Morgan Stanley this week:

• Positive Sentiment: Potentially major Anthropic IPO role: Morgan Stanley and Goldman Sachs are reportedly close to receiving leading roles in Anthropic’s anticipated IPO, which could involve a valuation near $2 trillion. The deal would strengthen Morgan Stanley’s technology and equity-underwriting franchise and provide a potentially meaningful source of fees and future business. Anthropic is also reportedly arranging a $15 billion revolving credit facility, with Morgan Stanley leading the process. Anthropic close to awarding Morgan Stanley and Goldman top roles in $2tn IPO
• Positive Sentiment: Strong recent earnings backdrop: Morgan Stanley’s latest quarterly results significantly exceeded expectations, with revenue up 27.1% year over year and earnings per share of $3.46 versus a $2.89 consensus estimate. The performance supports investor confidence in the firm’s trading, investment-banking and wealth-management businesses.
• Neutral Sentiment: Ongoing conference and client activity: Morgan Stanley is hosting its 24th Annual Global Healthcare Conference, while companies including Tempus, Attovia Therapeutics, Eaton and Southwest Airlines are scheduled to present. These events reinforce the firm’s role in institutional research and client engagement but are unlikely to materially affect near-term financial results. Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
• Negative Sentiment: Copyright dispute with X: Morgan Stanley has filed complaints against at least 16 X posts that allegedly shared copyrighted research and temporarily locked a prominent strategist’s account. The action may protect valuable intellectual property, but it also creates reputational and legal uncertainty and could disrupt the firm’s visibility on a major platform used by investors. Morgan Stanley Hands Elon Musk a New X Headache

Morgan Stanley Stock Performance

MS opened at $217.73 on Friday. Morgan Stanley has a 12-month low of $146.29 and a 12-month high of $232.25. The stock has a market cap of $343.42 billion, a price-to-earnings ratio of 17.60, a PEG ratio of 1.54 and a beta of 1.21. The business has a 50 day moving average of $215.70 and a 200-day moving average of $196.68. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 3.65.

Morgan Stanley (NYSE:MS) last issued its earnings results on Wednesday, July 15th. The financial services provider reported $3.46 EPS for the quarter, topping the consensus estimate of $2.89 by $0.57. Morgan Stanley had a return on equity of 19.31% and a net margin of 15.65%.The company had revenue of $21.35 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period in the previous year, the company posted $2.13 EPS. The firm’s revenue for the quarter was up 27.1% compared to the same quarter last year. On average, equities research analysts expect that Morgan Stanley will post 12.79 earnings per share for the current year.

Morgan Stanley Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Friday, July 31st were given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.1%. This is a positive change from Morgan Stanley’s previous quarterly dividend of $1.00. The ex-dividend date of this dividend was Friday, July 31st. Morgan Stanley’s dividend payout ratio (DPR) is presently 37.19%.

Morgan Stanley announced that its board has initiated a share repurchase program on Wednesday, June 24th that authorizes the company to buyback $20.00 billion in shares. This buyback authorization authorizes the financial services provider to reacquire up to 5.6% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board believes its stock is undervalued.

Analyst Upgrades and Downgrades

MS has been the subject of a number of recent research reports. Bank of America increased their price objective on shares of Morgan Stanley from $225.00 to $250.00 and gave the stock a “buy” rating in a research note on Tuesday, July 7th. Oppenheimer downgraded Morgan Stanley from a “market perform” rating to an “underperform” rating in a research report on Tuesday, June 30th. BMO Capital Markets upped their target price on Morgan Stanley from $240.00 to $250.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. The Goldman Sachs Group upped their price objective on Morgan Stanley from $211.00 to $233.00 and gave the stock a “neutral” rating in a research note on Monday, July 6th. Finally, Citigroup increased their price objective on Morgan Stanley from $220.00 to $235.00 and gave the company a “neutral” rating in a report on Friday, July 17th. Three research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $224.75.

About Morgan Stanley

Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.

The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.